Blog

Females experience worse outcomes in groin hernia repair

A systematic review and meta-analysis, analyzing 1,236,694 patients, revealed that females undergoing groin hernia repair suffer higher rates of recurrence (1.28), chronic pain (1.52), and surgical site infections (1.46) compared to males. Additionally, women are less likely to opt for minimally invasive surgery, exhibiting a relative risk of 0.82. These findings highlight the disparities in outcomes based on sex and emphasize the need for targeted research to improve surgical results for women.

Journal Article by Balthazar da Silveira CA, Mazzola Poli de Figueiredo S (…) Towfigh S et 4 al. in World J Surg

© 2024 International Society of Surgery/Société Internationale de Chirurgie (ISS/SIC).

read the whole article in World J Surg

open it in PubMed

New nomogram predicts postoperative survival in gallbladder cancer

A novel nomogram has been developed to predict postoperative survival in gallbladder cancer patients, incorporating eight critical factors including TNM stage and serum biomarkers. Performance metrics demonstrated consistent time-dependent concordance indices exceeding 0.70 and area under the curve surpassing 75% for 1-, 3-, and 5-year survival rates. These findings indicate strong prognostic capability and generalizability, offering clinicians a practical tool for enhancing decision-making and improving patient outcomes beyond traditional models.

Multicenter Study by Deng K, Xing J (…) Du S et 12 al. in World J Surg Oncol

© 2024. The Author(s).

read the whole article in World J Surg Oncol

open it in PubMed

Laparoscopic hepatectomy outperforms radiofrequency ablation for small tumors

A comparison of laparoscopic hepatectomy (LH) and radiofrequency ablation (RFA) revealed that LH provides significantly better overall survival (OS) and disease-specific survival (DSS) for small hepatocellular carcinoma patients. In matched cohorts, 1, 3, and 5-year OS and DSS rates favored LH over RFA. For tumors ≤2 cm, LH demonstrated a trend toward superiority in survival, indicating it should be prioritized as the treatment choice despite some nonsignificant p-values. Factors like AFP levels and tumor differentiation influenced outcomes.

Journal Article by Wang X, Chai X (…) Chen Q et 2 al. in Updates Surg

© 2024. The Author(s).

read the whole article in Updates Surg

open it in PubMed

Novel simulator enhances training for laparoscopic inguinal hernia repair

A new simulator for transabdominal preperitoneal laparoscopic inguinal hernia repair has been validated. This model, featuring an innovative exchangeable peritoneum, was highly rated by 24 surgeons for its realistic tactile feedback and anatomical fidelity. Performance evaluations revealed that surgical experts outperformed residents, achieving higher scores and faster procedure times. The simulator’s effectiveness suggests it could significantly reduce the training duration for laparoscopic techniques, alleviating the steep learning curve faced by novice surgeons.

Validation Study by Shibuya A, Isobe Y (…) Matsumoto K et 3 al. in Asian J Endosc Surg

© 2024 The Author(s). Asian Journal of Endoscopic Surgery published by Asia Endosurgery Task Force and Japan Society of Endoscopic Surgery and John Wiley & Sons Australia, Ltd.

read the whole article in Asian J Endosc Surg

open it in PubMed

Surgical intervention improves survival in liver-only gastric metastases

Analysis of 10,977 patients with gastric adenocarcinoma and liver-only metastases revealed that those undergoing primary tumor resection combined with liver metastasectomy experienced significantly longer median overall survival (18.6 months) compared to non-surgical treatment (6.5 months). The study indicates that surgical resection, especially in highly selected patients with favorable biology, is associated with improved survival outcomes. Adjusted hazard ratios affirmed the enhanced benefit of the combined surgical approach over other treatment options.

Journal Article by Ziogas IA, Thielen ON (…) Mungo B et 8 al. in Ann Surg Oncol

© 2024. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

MVI grading severity influences survival outcomes after liver resection

A multicenter study involving 233 early-stage hepatocellular carcinoma patients revealed that microvascular invasion (MVI) grading significantly affects long-term outcomes post-laparoscopic liver resection. Specifically, median overall survival (OS) was 84.9 months for M0, 40.1 months for M1, and 25.2 months for M2. Likewise, recurrence-free survival (RFS) showed similar disparities. M1 and M2 classifications were identified as independent risk factors, underscoring the necessity for enhanced surveillance and therapy for MVI patients, particularly those classified as M2.

Journal Article by Yang S, Ni H (…) Ming Z et 6 al. in Am J Surg

Copyright © 2024 Elsevier Inc. All rights reserved.

read the whole article in Am J Surg

open it in PubMed

Significant disparities in treatment for locally advanced pancreatic cancer

Treatment trends for locally advanced pancreatic cancer reveal that 67.67% of patients received primarily chemotherapy, with notable improvement in surgical resection rates over time. However, 41.19% also received radiation, yet many patients went untreated or did not receive guideline-recommended treatment (GRT). Socioeconomic factors like race, education, and insurance significantly influenced access to care and overall survival rates, highlighting persistent inequalities despite advancements in treatment options.

Journal Article by Thomas AS, Tehranifar P (…) Kluger MD et 7 al. in J Surg Oncol

© 2024 Wiley Periodicals LLC.

read the whole article in J Surg Oncol

open it in PubMed

Contrast-enhanced ultrasound enhances survival in liver metastases

In a study involving 130 patients with unresectable colorectal cancer liver metastases, the use of contrast-enhanced intraoperative ultrasound (ce-ious) significantly improved hepatic recurrence-free survival rates compared to standard intraoperative ultrasound alone. Specifically, the ce-ious group demonstrated a lower recurrence rate (hazard ratio 0.55), especially in those with bilobar metastases, fewer than three tumors, or extrahepatic metastasis. This technique altered treatment strategies in nearly 40% of patients, underscoring its clinical value.

Journal Article by Li H, Shi M (…) Zou R et 8 al. in Dig Liver Dis

Copyright © 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

read the whole article in Dig Liver Dis

open it in PubMed

Day-case laparoscopic cholecystectomy is a safe option for gallbladder disease.

Day-case laparoscopic cholecystectomy (DCLC) is proven safe and effective for treating symptomatic gallstones, offering benefits like shorter hospital stays and improved patient satisfaction. Key findings indicate that unexpected admissions arise mainly from postoperative nausea, vomiting, and pain, while anesthesia pathways enhance day-case rates. Importantly, complication rates post-DCLC show no significant difference compared to inpatient procedures, reinforcing the potential for DCLC to become the standard approach in select patients, thus optimizing healthcare resources.

Review by Abuahmed M and Rashid R in Langenbecks Arch Surg

© 2024. Crown.

read the whole article in Langenbecks Arch Surg

open it in PubMed

Neoadjuvant immunotherapy does not increase postoperative complications.

A comprehensive analysis of 953,612 cancer surgery patients reveals neoadjuvant immunotherapy is not significantly linked to major postoperative morbidity. The study, which evaluated cases across multiple cancer types, found a pooled odds ratio of 0.98, indicating no increased risk. Specifically, adjusted odds ratios varied by cancer type, with none showing significant associations with complications. The findings suggest that surgical procedures following neoadjuvant immunotherapy are generally safe, providing reassurance for ongoing treatment protocols.

Letter by Habib DRS, Shou M (…) Khan A et 4 al. in Ann Surg Oncol

© 2024. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed